Lack of renoprotective effects of dopamine and furosemide during cardiac surgery

Journal of the American Society of Nephrology

Volumn 11, Issue 1, 2000, Pages 97-104

  Lassnigg, Andrea ^b   Donner, Eva ^b   Grubhofer, Georg ^b   Presterl, Elisabeth ^b   Druml, Wilfred ^b   Hiesmayr, Michael ^a  

^a Univ Clinic of Anesthesia (HTG)   (Austria)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR; FUROSEMIDE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HEART SURGERY; HUMAN; INTENSIVE CARE UNIT; KIDNEY DISEASE; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0033982134     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Hilberman M, Myers BD, Carrie BJ, Derby G, Jamison RL, Stinson EB: Acute renal failure following cardiac surgery. J Thorac Cardiovasc Surg 77: 880-888, 1979
2. Star RA: Treatment of acute renal failure. Kidney Int 54: 1817-1831, 1998
3. Zanardo G, Michielon P, Paccagnella A, Rosi P, Calo M, Salandin V, Da Ros A, Michieletto F, Simini G: Acute renal failure in the patient undergoing cardiac operation: Prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg 107: 1489-1495, 1994
4. Levy EM, Viscoli CM, Horwitz RI: The effect of acute renal failure on mortality: A cohort analysis. JAMA 275: 1489-1494, 1996
5. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J: Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 104: 343-348, 1998
6. Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT: Renal dysfunction after myocardial revascularization: Risk factors, adverse outcomes, and hospital resource utilization. Ann Intern Med 128: 194-203, 1998
7. Verrier ED, Boyle EM Jr: Endothelial cell injury in cardiovascular surgery. Ann Thorac Surg 62: 915-922, 1996
8. Gailiunas P Jr, Chawla R, Lazarus JM, Cohn L, Sanders J, Merrill JP: Acute renal failure following cardiac operations. J Thorac Cardiovasc Surg 79: 241-243, 1980
9. Sladen R, Prough D: Perioperative renal protection: Crit Care Clin 9: 314-331, 1997
10. Ip Yam PC, Murphy S, Baines M, Fox MA, Desmond MJ, Innes PA: Renal function and proteinuria after cardiopulmonary bypass: The effects of temperature and mannitol. Anesth Analg 78: 842-847, 1994
11. Denton MD, Chertow GM, Brady HR: "Renal-dose" dopamine for the treatment of acute renal failure: Scientific rationale, experimental studies and clinical trials. Kidney Int 50: 4-14, 1996
12. Hollenberg NK, Adams DF, Mendell P, Abrams HL, Merrill JP: Renal vascular responses to dopamine: Haemodynamic and angiographic observations in normal man. Clin Sci Mol Med 45: 733-742, 1973
13. Rosenblum R, Tai AR, Lawson D: Dopamine in man: Cardiorenal hemodynamics in normotensive patients with heart disease. J Pharmacol Exp Ther 183: 256-263, 1972
14. Lee MR: Dopamine and the kidney: Ten years on. Clin Sci Colch 84: 357-375, 1993
15. Bello Reuss E, Higashi Y, Kaneda Y: Dopamine decreases fluid reabsorption in straight portions of rabbit proximal tubule. Am J Physiol 242: F634-F640, 1982
16. Bryan AG, Bolsin SN, Vianna PT, Haloush H: Modification of the diuretic and natriuretic effects of a dopamine infusion by fluid loading in preoperative cardiac surgical patients. J Cardiothorac Vasc Anesth 9: 158-163, 1995
17. Gelman S: Low-dose dopamine: There is a scientific rationale [Abstract]. Br J Anaesth 79: 546, 1997
18. Brown CB, Ogg CS, Cameron JS: High dose frusemide in acute renal failure: A controlled trial. Clin Nephrol 15: 90-96, 1981
19. Shilliday IR, Quinn KJ, Allison ME: Loop diuretics in the management of acute renal failure: A prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant 12: 2592-2596, 1997
20. Heyman SN, Brezis M, Greenfeld Z, Rosen S: Protective role of furosemide and saline in radiocontrast-induced acute renal failure in the rat. Am J Kidney Dis 14: 377-385, 1989
21. Brezis M, Rosen S, Silva P, Epstein FH: Transport activity modifies thick ascending limb damage in the isolated perfused kidney. Kidney Int 25: 65-72, 1984
22. Driscoll DF, Pinson CW, Jenkins RL, Bistrian BR: Potential protective effects of furosemide against early renal injury in liver transplant patients receiving cyclosporine-A. Crit Care Med 17: 1341-1343, 1989
23. Mackay IG, Muir AL, Watson ML: Contribution of prostaglandins to the systemic and renal vascular response to frusemide in normal man. Br J Clin Pharmacol 17: 513-519, 1984
24. Solomon R, Werner C, Mann D, D'Elia J, Silva P: Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331: 1416-1420, 1994
25. Brezis M, Rosen S: Hypoxia of the renal medulla: Its implications for disease. N Engl J Med 332: 647-655, 1995
26. Duke GJ, Bersten AD: Dopamine and renal salvage in the critically ill patient. Anaesth Intensive Care 20: 277-287, 1992
27. Baldwin L, Henderson A, Hickman P: Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med 120: 744-747, 1994
28. Szerlip HM: Renal-dose dopamine: Fact and fiction. Ann Intern Med 115: 153-154, 1991
29. Weinstein JM, Heyman S, Brezis M: Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron 62: 413-415, 1992
30. Cantarovich F, Galli C, Benedetti L, Chena C, Castro L, Correa C, Perez Loredo J, Fernandez JC, Locatelli A, Tizado J: High dose frusemide in established acute renal failure. Br Med J 4: 449-450, 1973
31. Martin SJ, Danziger LH: Continuous infusion of loop diuretics in the critically ill: A review of the literature. Crit Care Med 22: 1323-1329, 1994
32. Lal S, Murtagh JG, Pollock AM, Fletcher E, Binnion PF: Acute haemodynamic effects of frusemide in patients with normal and raised left atrial pressures. Br Heart J 31: 711-717, 1969
33. Nelson GI, Ahuja RC, Silke B, Okoli RC, Hussain M, Taylor SH: Haemodynamic effects of frusemide and its influence on repetitive rapid volume loading in acute myocardial infarction. Eur Heart J 4: 706-711, 1983
34. Nelson GI, Silke B, Forsyth DR, Verma SP, Hussain M, Taylor SH: Hemodynamic comparison of primary venous or arteriolar dilatation and the subsequent effect of furosemide in left ventricular failure after acute myocardial infarction. Am J Cardiol 52: 1036-1040, 1983
35. Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN: Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure: Activation of the neurohumoral axis. Ann Intern Med 103: 1-6, 1985
36. Davis RF, Lappas DG, Kirklin JK, Buckley MJ, Lowenstein E: Acute oliguria after cardiopulmonary bypass: Renal functional improvement with low-dose dopamine infusion. Crit Care Med 10: 852-856, 1982
37. Lherm T, Troche G, Rossignol M, Bordes P, Zazzo JF: Renal effects of low-dose dopamine in patients with sepsis syndrome or septic shock treated with catecholamines. Intensive Care Med 22: 213-219, 1996
38. Flancbaum L, Choban PS, Dasta JF: Quantitative effects of low-dose dopamine on urine output in oliguric surgical intensive care unit patients. Crit Care Med 22: 61-68, 1994
39. Poison RJ, Park GR, Lindop MJ, Farman JV, Calne RY, Williams R: The prevention of renal impairment in patients undergoing orthotopic liver grafting by infusion of low dose dopamine. Anaesthesia 42: 15-19, 1987
40. Hoogenberg K, Smit AJ, Girbes AR: Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers. Crit Care Med 26: 260-265, 1998
41. Kapoor A, Sinha N, Sharma RK, Shrivastava S, Radhakrishnan S, Goel PK, Bajaj R: Use of dopamine in prevention of contrast induced acute renal failure: A randomised study. Int J Cardiol 53: 233-236, 1996
42. Lema G, Urzua J, Jalil R, Canessa R, Moran S, Sacco C, Medel J, Irarrazaval M, Zalaquett R, Fajardo C, Meneses G: Renal protection in patients undergoing cardiopulmonary bypass with preoperative abnormal renal function. Anesth Analg 86: 3-8, 1998
43. Parker S, Carlon GC, Isaacs M, Howland WS, Kahn RC: Dopamine administration in oliguria and oliguric renal failure. Crit Care Med 9: 630-632, 1981
44. Pavoni V, Verri M, Ferraro L, Volta CA, Paparella L, Capuzzo M, Pavanelli L, Buccoliero C, Beani L, Alvisi R, Gritti G: Plasma dopamine concentration and effects of low dopamine doses on urinary output after major vascular surgery. Kidney Int 53: S75-S80, 1998
45. Myles PS, Buckland MR, Schenk NJ, Cannon GB, Langley M, Davis BB, Weeks AM: Effect of "renal-dose" dopamine on renal function following cardiac surgery. Anaesth Intensive Care 21: 56-61, 1993
46. Thadhani R, Pascual M, Bonvcntrc JV: Acute renal failure. N Engl J Med 334: 1448-1460, 1996
47. Chiolero R, Borgeat A, Fisher A: Postoperative arrhythmias and risk factors after open heart surgery. Thorac Cardiovasc Surg 39: 81-84, 1991
48. Goldberg LI: Dopamine: Clinical uses of an endogenous catecholamine. N Engl J Med 291: 707-710, 1974
49. van de Borne P, Oren R, Somers VK: Dopamine depresses minute ventilation in patients with heart failure. Circulation 98: 126-131, 1998
50. Duke GJ, Briedis JH, Weaver RA: Renal support in critically ill patients: Low-dose dopamine or low-dose dobutamine? Crit Care Med 22: 1919-1925, 1994
51. Van den Berghe G, de Zegher F: Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 24: 1580-1590, 1996